Abstract. Hypomagnesemia and low erythrocyte magnesium content are both common findings in non-insulin-dependent diabetic subjects. Moreover 
\ m=+-\ 0.3 vs 8.0 \ m=+-\ 0.1 mmol/l, p < 0.05) and an increase in acute insulin response after iv glucose (37.1 \m=+-\2.3 vs \m=-\14.7 \m=+-\0.9 pmol \ m=. \ 1\ m=-\ 1 \ m=. \ (10 mi n)\m=-\1, p < 0.01) and after iv arginine (151 \ m=+-\ 22 vs 81 \m=+-\15 pmol \m=.\ 1\ m=-\ 1 \ m=. \ (10 min)\m=-\1, p < 0.01), re- spectively. Plasma glucagon levels were unaffected by chronic dietary magnesium supplementation as well under basal conditions as in response to arginine. Net increase in acute insulin response after iv glucose and after iv arginine was significantly correlated to the net increase in erythrocyte magnesium content after dietary magnesium supplementation. We conclude that magnesium administration may be a useful adjuvant to the classic hypoglycemic agents in the treatment of non-insulin\x=req-\ dependent diabetic subjects.
Magnesium is a necessary intracellular cofactor for many enzymes and plays an essential role in pro¬ tein synthesis (1 (4) . A low erythrocyte magnesium content, a condition associated with insulin resistance, is also found in the elderly (5) .
In the light of these findings the aim of the pres¬ ent study was to investigate the effects of magne¬ sium administration on the B-and A-cell responses to iv glucose and to iv arginine in elderly, moder¬ ately obese, non-insulin-dependent diabetic pa¬ tients.
Patients and Methods

Subjects
Eight elderly, moderately obese, non-insulin-dependent (Type II) diabetic patients were studied ( Arginine pulse produced an increase in AIR (81 ± 15 vs 151 ± 22 pmol (Fig. 3) . On •min-1, p < 0.05) was significantly lower after magnesium than placebo administration.
Net increases in AIR and erythrocyte magne¬ sium content were significantly and positively correlated (r = 0.71, p < 0.01) at the end of the mag¬ nesium administration period.
Discussion
Previous studies have reported low plasma and erythrocyte magnesium levels in non-insulin-dependent diabetic subjects (2, 7, 8 (9, 10) .
In the light of these findings, it has been hypo¬ thesized that a chronic administration of magne¬ sium salts produces beneficial effects on glucose homeostasis in diabetic subjects. The present study investigated the effects of die¬ tary magnesium supplementation on glucose and arginine-induced A-and B-cell response in elderly non-insulin-dependent diabetic subjects. Our data reveal that magnesium administration slightly but significantly enhances B-cell response to glucose and arginine.
These data might be explained by recent in vitro evidence (9, 10) showing that magnesium uptake at the B-cell level increased or decreased by agents known to stimulate or inhibit insulin biosynthesis, respectively. In contrast, pancreatic insulin content has been shown to be decreased in magnesium deficient rats (10) . Thus, these authors hypothesize a possible link between the two phenomena.
Nevertheless, an additional explanation may also be suggested. Magnesium is involved in the regulation of B-cell function, since in vitro varia¬ tions of extracellular magnesium concentrations modulate intracellular potassium and B-cell re¬ sponse to glucose (11) . Though not demonstrated in the endocrine pancreas, such a loss of cellular potassium is known to occur in other tissues of magnesium deficient rats (12, 13) and it might con¬ tribute to a further impairment of B-cell function in non-insulin-dependent diabetes mellitus. A poor B-cell response may be secondary to a de¬ crease in the potassium content (14) (15) (16) .
Furthermore, the correlation found in the pres¬ ent study between net increase in AIR and net in¬ crease in erythrocyte magnesium content at the end of the magnesium administration period seems to strengthen the hypothesis suggested above. As far as plasma glucose level changes are concerned, we believe that an appropriate or re¬ stored intracellular magnesium content might im¬ prove insulin action, as suggested by Durlach & Rayssignier (17) and recently demonstrated by our¬ selves (unpublished observations). Furthermore, a possibile simple relationship between improved glucose metabolsim and enhanced B-cell response to nutrients or a combination of both possibilities cannot be excluded.
In conclusion, the present study shows that die¬ tary magnesium supplementation can enhance in¬ sulin secretion, thus contributing to the improve¬ ment of metabolic control in non-insulin-depend¬ ent diabetic subjects.
